Data protection Impressum

Financing

Asceneuron has secured USD 100 million in Series C funding to advance its mission of developing OGA inhibitors for neurodegenerative diseases like Alzheimer's.

Asceneuron raises USD 100 million to advance Alzheimer’s treatment

16 July 2024

Swisspod has secured funding to build the world's largest Hyperloop test facility in the US, revolutionizing high-speed transportation.

Swisspod to build world’s largest hyperloop testing hub

15 July 2024

Biopôle-based start-up Vanarix has secured CHF 4 million to initiate new clinical trials and automate the manufacturing of its Cartibeads.

Vanarix raises CHF 4 million to advance cartilage regeneration

15 July 2024

With a performance of 138.4% of the EU average, Switzerland is at the forefront of fostering innovation, displaying particular strengths in education-related indicators, scientific publications, and environment-related technologies.

Switzerland continues to lead the European Innovation Scoreboard in 2024

10 July 2024

Forestay Capital, a Geneva-based venture capital firm specializing in growth-stage investments, has closed its second fund at USD 220 million, backed by major European and Swiss family offices.

Geneva VC Forestay Capital secures USD 220 million towards Enterprise AI and SaaS

8 July 2024

The canton of Neuchâtel is positioning itself as a future leader in medical diagnostic technologies with the creation of a new innovation cluster.

Neuchâtel embraces innovation in medical diagnostic technologies

8 July 2024

The FONGIT Innovation Fund has awarded funding to three cutting-edge tech projects: CHF 100,000 seed loans for returning winners Planeto and HekeTiss, and a CHF 50,000 grant for newcomer LightEye.

CERN and UNIGE spin-offs awarded FIF Funding

2 July 2024

WattAnyWhere provides a fuel cell-based, pollutant-free generator that converts renewable ethanol into clean electricity for Electric Vehicle (EV) fast-charging.

WattAnyWhere raises CHF 2.2 million to convert ethanol into clean electricity

1 July 2024

iOnctura has secured EUR 80 million in a Series B funding round to advance innovative cancer therapies, with a focus on neglected cancers such as uveal melanoma.

iOnctura secures EUR 80 million Series B financing to advance cancer treatments

25 June 2024

Switzerland ranks as the second most competitive country in the 2024 IMD World Competitiveness Ranking, demonstrating significant improvements in economic performance and business efficiency.

Switzerland secures second spot in IMD’s 2024 World Competitiveness Ranking

19 June 2024

1 … 6 7 8 9 10 11 12 13 14 … 32